B-cell depletion with obinutuzumab for the treatment of IgG4-related disease

Eur J Intern Med. 2023 Oct:116:155-156. doi: 10.1016/j.ejim.2023.07.019. Epub 2023 Jul 21.
No abstract available

Keywords: Obinutuzumab is a safe and effective treatment for IgG4-RD.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • B-Lymphocytes
  • Humans
  • Immunoglobulin G4-Related Disease* / drug therapy

Substances

  • obinutuzumab
  • Antibodies, Monoclonal, Humanized